Aktis Oncology, Inc. (AKTS) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Collaboration Revenue | 3.4M | FY2026-Q2 |
Back to AKTS overview · AKTS earnings · AKTS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.